Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer

Conditions

• Caregiving for Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Psychosocial Intervention for Parental Caregivers of AYA with Cancer — BEHAVIORAL
  A new adaptation of an evidence-supported intervention, the SMART-3RP program, to address psychological symptoms and promote well-being among parental caregivers of AYA with cancer.

Study Details

The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP(E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYA with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.

Key Dates

Start date

Oct 22, 2025

Status verified

Aug 2025

Primary completion

Apr 30, 2026

Completion

Aug 31, 2026

Study Design

Enrollment

48 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: Psychosocial Intervention for Parental Caregivers of AYA with Cancer
  The study team aims to evaluate the feasibility and acceptability of the adapted psychosocial intervention to 1) improve psychological resiliency to stress and 2) reduce symptoms of depression, anxiety, and post-traumatic stress among parental caregivers, through a single-arm open pilot trial of 32 parents.

Primary Outcome Measure

Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll [ Time Frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months) ]

Central Contacts

• Zeba N Ahmad, Ph.D.
  16177241586
  [email protected]
• Xinghan Zhu, B.S.
  6177247593
  [email protected]

Locations (1)

Find similar trials in Boston, MA